Skip to main content
STRO logo
STRO
(NASDAQ)
Sutro Biopharma, Inc.
$29.55-- (--)
Loading... - Market loading

Sutro Biopharma, Inc. (STRO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Sutro Biopharma, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy
Based on 11 unique analysts
(13 total ratings in last 90 days)
High Confidence10.0:1 Buy/Sell

Average Price Target

$49.44
67.31% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest STRO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Supawat Thongthip
Truist
BuyInitiates
$50.00
Charles Zhu
LifeSci Capital
BuyMaintains
$54.00
Lukas Shumway
Barclays
BuyInitiates
$56.00
Andres Y. Maldonado
HC Wainwright
BuyMaintains
$50.00
Tazeen Ahmad
BofA Securities
SellReiterates
-
Tazeen Ahmad
BofA Securities
SellReiterates
-
David Nierengarten
Wedbush
BuyUpgrades
$60.00
Andrew Berens
Leerink Partners
BuyReiterates
$38.00 $43.00
Tara Bancroft
TD Cowen
BuyMaintains
-
Joseph Catanzaro
Mizuho
BuyInitiates
$50.00
Reni J. Benjamin
Citizens
BuyMaintains
$35.00 $41.00
Reni Benjamin
Citizens JMP
BuyMaintains
$35.00 $41.00
Reni J. Benjamin
Citizens
BuyMaintains
$23.00 $35.00

Frequently Asked Questions

What is the analyst consensus rating for STRO?

The analyst consensus rating for STRO is "Buy" based on 11 analyst recommendations.

What is the average price target for STRO?

The average 12-month price target for STRO is $49.44, representing an upside of 67.3% from the current price of $29.55.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.